Hitting multiple targets with multimeric ligands
暂无分享,去创建一个
Robert J Gillies | Josef Vagner | Haiyong Han | R. Gillies | V. Hruby | J. Vagner | Haiyong Han | E. Mash | H. Handl | Victor J Hruby | Heather L Handl | Eugene Mash
[1] P. Conn,et al. Potency enhancement of a GnRH agonist: GnRH-receptor microaggregation stimulates gonadotropin release. , 1982, Endocrinology.
[2] R. Bittman,et al. Inhibition of protein kinase C(alpha) by dequalinium analogues: dependence on linker length and geometry. , 2000, Journal of medicinal chemistry.
[3] U. Marx,et al. The structure of human parathyroid hormone‐related protein(1–34) in near‐physiological solution , 1999, FEBS letters.
[4] T. L. Blundell,et al. The relation of polypeptide hormone structure and flexibility to receptor binding: The relevance of X-ray studies on insulins, glucagon and human placental lactogen , 1975, Molecular and Cellular Biochemistry.
[5] K. Sakaguchi,et al. Dimerization of neurokinin A and B COOH-terminal heptapeptide fragments enhanced the selectivity for tachykinin receptor subtypes. , 1988, European journal of pharmacology.
[6] J. F. Stoddart,et al. Probing polyvalency in artificial systems exhibiting molecular recognition. , 2002, The Journal of organic chemistry.
[7] V. Seredyuk,et al. Bolaforms with fourteen galactose units: a proposed site-directed cohesion of cancer cells. , 2004, Organic letters.
[8] B. Pullman,et al. The electronic structure of the purine-pyrimidine pairs of DNA. , 1959, Biochimica et biophysica acta.
[9] G M Whitesides,et al. A trivalent system from vancomycin.D-ala-D-Ala with higher affinity than avidin.biotin. , 1998, Science.
[10] R. Mattson,et al. Bivalent indoles exhibiting serotonergic binding affinity , 1995 .
[11] B. Baird,et al. Highly effective poly(ethylene glycol) architectures for specific inhibition of immune receptor activation. , 2003, Biochemistry.
[12] M. Shive,et al. Surface modification of liposomes for selective cell targeting in cardiovascular drug delivery. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[13] W. Hol,et al. High-Affinity Pentavalent Ligands of Escherichia coli Heat-Labile Enterotoxin by Modular Structure-Based Design , 2000 .
[14] R. Schwyzer,et al. Tobacco mosaic virus-enkephalin conjugates: Potentiation of opioid activity , 1981, Peptides.
[15] L. Tan,et al. Her-2/neu and breast cancer. , 2001, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[16] G. Whitesides,et al. Nonstatistical binding of a protein to clustered carbohydrates. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[17] D. L. Larson,et al. Opioid antagonist activity of naltrexone-derived bivalent ligands: importance of a properly oriented molecular scaffold to guide "address" recognition at kappa opioid receptors. , 1996, Journal of medicinal chemistry.
[18] E. Whalley,et al. A new class of bradykinin antagonists: synthesis and in vitro activity of bissuccinimidoalkane peptide dimers. , 1992, Journal of medicinal chemistry.
[19] R. Gaspar,et al. A growth factor antagonist as a targeting agent for sterically stabilized liposomes in human small cell lung cancer. , 2001, Biochimica et biophysica acta.
[20] I. Tinoco,et al. The stability of helical polynucleotides: base contributions. , 1962, Journal of molecular biology.
[21] R. Gillies,et al. Expression-driven reverse engineering of targeted imaging and therapeutic agents , 2003, Expert opinion on therapeutic targets.
[22] D. L. Larson,et al. Opioid agonist and antagonist bivalent ligands as receptor probes. , 1982, Life sciences.
[23] H. Blöcker,et al. Predicting DNA duplex stability from the base sequence. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[24] G Poste,et al. Measurement of the lateral mobility of cell surface components in single, living cells by fluorescence recovery after photobleaching. , 1976, Journal of supramolecular structure.
[25] D. Cram,et al. Host-Guest Chemistry: Complexes between organic compounds simulate the substrate selectivity of enzymes. , 1974, Science.
[26] M. Mrksich,et al. Model Systems for Studying Polyvalent Carbohydrate Binding Interactions , 2002 .
[27] M. Lerner,et al. Synthesis and characterization of bivalent peptide ligands targeted to G-protein-coupled receptors. , 1996, Chemistry & biology.
[28] W. Bode,et al. Bivalent inhibition of human beta-tryptase. , 2001, Chemistry & biology.
[29] R. Grubbs,et al. Inhibition of cell adhesion to fibronectin by oligopeptide-substituted polynorbornenes. , 2001, Journal of the American Chemical Society.
[30] Ji Young Kim,et al. Multivalent Inhibition of AB5 Toxins , 2001 .
[31] J. Wetmur. DNA probes: applications of the principles of nucleic acid hybridization. , 1991, Critical reviews in biochemistry and molecular biology.
[32] P. Portoghese,et al. Narcotic antagonistic potency of bivalent ligands which contain .beta.-naltrexamine. Evidence for simultaneous occupation of proximal recognition sites , 1982 .
[33] R L Juliano,et al. (Arg-Gly-Asp)n-albumin conjugates as a model substratum for integrin-mediated cell adhesion. , 1989, Experimental cell research.
[34] R. Schiffelers,et al. Peptide-targeted PEG-liposomes in anti-angiogenic therapy. , 2003, International journal of pharmaceutics.
[35] A. Plückthun,et al. New protein engineering approaches to multivalent and bispecific antibody fragments. , 1997, Immunotechnology : an international journal of immunological engineering.
[36] V. Hruby,et al. Conformational and dynamic considerations in peptide structure-function studies , 1982, Peptides.
[37] L. Kiessling,et al. Chapter 29. Principles for multivalent ligand design , 2000 .
[38] J. Wetmur. Hybridization and renaturation kinetics of nucleic acids. , 1976, Annual review of biophysics and bioengineering.
[39] Watt W. Webb,et al. Imaging coexisting fluid domains in biomembrane models coupling curvature and line tension , 2003, Nature.
[40] V. Hruby,et al. Human epidermal melanocyte and keratinocyte melanotropin receptors: visualization by melanotropic peptide conjugated macrospheres (polyamide beads) , 1997, Experimental dermatology.
[41] F. Lemonnier,et al. A novel multivalent human CTL peptide construct elicits robust cellular immune responses in HLA-A*0201 transgenic mice: implications for HTLV-1 vaccine design. , 2003, Vaccine.
[42] R. Standaert,et al. Chemically induced dimerization of dihydrofolate reductase by a homobifunctional dimer of methotrexate. , 2000, Chemistry & biology.
[43] R. Liskamp,et al. Amino propynyl benzoic acid building block in rigid spacers of divalent ligands binding to the Syk SH2 domains with equally high affinity as the natural ligand. , 2003, Bioorganic & medicinal chemistry letters.
[44] M. Germann,et al. Design of Peptides with High Affinities for Heparin and Endothelial Cell Proteoglycans* , 2000, The Journal of Biological Chemistry.
[45] Jason E Gestwicki,et al. Influencing receptor-ligand binding mechanisms with multivalent ligand architecture. , 2002, Journal of the American Chemical Society.
[46] S. Das,et al. Binding of multivalent carbohydrates to concanavalin A and Dioclea grandiflora lectin. Thermodynamic analysis of the "multivalency effect". , 2000, The Journal of biological chemistry.
[47] P. Hajduk,et al. Discovering High-Affinity Ligands for Proteins: SAR by NMR , 1996, Science.
[48] D M Crothers,et al. The influence of polyvalency on the binding properties of antibodies. , 1972, Immunochemistry.
[49] J. Changeux,et al. Allosteric proteins and cellular control systems. , 1963, Journal of molecular biology.
[50] S Cusack,et al. Kinetic Analysis of Adenovirus Fiber Binding to Its Receptor Reveals an Avidity Mechanism for Trimeric Receptor-Ligand Interactions* , 2001, The Journal of Biological Chemistry.
[51] R. Britten,et al. Repeated sequences in DNA. Hundreds of thousands of copies of DNA sequences have been incorporated into the genomes of higher organisms. , 1968, Science.
[52] K. M. Parkhurst,et al. Kinetic studies by fluorescence resonance energy transfer employing a double-labeled oligonucleotide: hybridization to the oligonucleotide complement and to single-stranded DNA. , 1995, Biochemistry.
[53] Deborah L. Higgins,et al. Multivalent drug design. Synthesis and in vitro analysis of an array of vancomycin dimers. , 2003, Journal of the American Chemical Society.
[54] W. Jencks,et al. On the attribution and additivity of binding energies. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[55] R. Schwyzer,et al. Tobacco mosaic virus as a carrier for small molecules: Artificial receptor antibodies and superhormones , 1981, Biopolymers.
[56] R. Huber,et al. Synthesis of bivalent inhibitors of eucaryotic proteasomes , 2000, Journal of peptide science : an official publication of the European Peptide Society.
[57] V. Hruby,et al. Melanotropic peptide-conjugated beads for microscopic visualization and characterization of melanoma melanotropin receptors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[58] A. M. Riley,et al. Dimers of D-myo-inositol 1,4,5-trisphosphate: design, synthesis, and interaction with Ins(1,4,5)P3 receptors. , 2004, Bioconjugate chemistry.
[59] A. M. Riley,et al. Interactions of Inositol 1,4,5-Trisphosphate (IP3) Receptors with Synthetic Poly(ethylene glycol)-linked Dimers of IP3 Suggest Close Spacing of the IP3-binding Sites* , 2002, The Journal of Biological Chemistry.
[60] Jean-Luc Coll,et al. Template assembled cyclopeptides as multimeric system for integrin targeting and endocytosis. , 2004, Journal of the American Chemical Society.
[61] Jason E Gestwicki,et al. Control of multivalent interactions by binding epitope density. , 2002, Journal of the American Chemical Society.
[62] V. Hruby,et al. Multivalent melanotropic peptide and fluorescent macromolecular conjugates: new reagents for characterization of melanotropin receptors. , 1994, Bioconjugate chemistry.
[63] E. Toone,et al. The cluster glycoside effect. , 2002, Chemical reviews.
[64] Hong Qian,et al. Nanometre-level analysis demonstrates that lipid flow does not drive membrane glycoprotein movements , 1989, Nature.
[65] J. Sridhar,et al. New bivalent PKC ligands linked by a carbon spacer: enhancement in binding affinity. , 2003, Journal of medicinal chemistry.
[66] P. Pauwels,et al. Dimerization of sumatriptan as an efficient way to design a potent, centrally and orally active 5-HT1B agonist. , 1998, Bioorganic & medicinal chemistry letters.
[67] N. Gates,et al. Kinetics of Renaturation of DNA , 2003 .
[68] G. Boons,et al. High-avidity, low-affinity multivalent interactions and the block to polyspermy in Xenopus laevis. , 2002, Journal of the American Chemical Society.
[69] R. Kramer,et al. Spanning binding sites on allosteric proteins with polymer-linked ligand dimers , 1998, Nature.
[70] K. Jacobson,et al. New insights into membrane dynamics from the analysis of cell surface interactions by physical methods. , 1995, Current opinion in cell biology.
[71] W. Bode,et al. Bivalent inhibition of human β-tryptase , 2001 .
[72] L. Kiessling,et al. Synthetic multivalent ligands in the exploration of cell-surface interactions. , 2000, Current opinion in chemical biology.
[73] P. Carlier,et al. Dual-site binding of bivalent 4-aminopyridine- and 4-aminoquinoline-based AChE inhibitors: contribution of the hydrophobic alkylene tether to monomer and dimer affinities. , 1999, Bioorganic & medicinal chemistry.
[74] Y. C. Lee,et al. Neoglycoconjugates : preparation and applications , 1994 .
[75] R. Rownd,et al. Denaturation and Renaturation of Deoxyribonucleic Acid12 , 1963 .
[76] H R Hoogenboom,et al. Design and application of diabodies, triabodies and tetrabodies for cancer targeting. , 2001, Journal of immunological methods.
[77] J. Stewart,et al. Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines by a “biased agonist” mechanism , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[78] A Kusumi,et al. Compartmentalized structure of the plasma membrane for receptor movements as revealed by a nanometer-level motion analysis , 1994, The Journal of cell biology.
[79] Randy J. Read,et al. Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands , 2000, Nature.
[80] George M Whitesides,et al. Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors. , 1998, Angewandte Chemie.
[81] V. Hruby,et al. Human epidermal melanocyte and keratinocyte melanocortin receptors: visualization by melanotropic peptide conjugated microspheres (latex beads). , 1996, Pigment cell research.
[82] H. Kodama,et al. Dimeric chemotactic peptides discriminate between chemotaxis and superoxide production of human neutrophils. , 1995, Journal of biochemistry.
[83] M Baba,et al. Structure-activity relationship studies with symmetric naphthalenesulfonic acid derivatives. Synthesis and influence of spacer and naphthalenesulfonic acid moiety on anti-HIV-1 activity. , 1993, Journal of medicinal chemistry.
[84] Robert J Gillies,et al. Novel targeting strategy based on multimeric ligands for drug delivery and molecular imaging: homooligomers of alpha-MSH. , 2004, Bioorganic & medicinal chemistry letters.
[85] W. Atkins,et al. Novel class of bivalent glutathione S-transferase inhibitors. , 2003, Biochemistry.
[86] C. Verlinde,et al. Solution and crystallographic studies of branched multivalent ligands that inhibit the receptor-binding of cholera toxin. , 2002, Journal of the American Chemical Society.
[87] C. Hill,et al. Stoichiometry of Active Smad-Transcription Factor Complexes on DNA* , 2002, The Journal of Biological Chemistry.
[88] M. Matrosovich. Towards the development of antimicrobial drugs acting by inhibition of pathogen attachment to host cells: A need for polyvalency , 1989, FEBS letters.
[89] P. Pauwels,et al. Serotonin dimers: application of the bivalent ligand approach to the design of new potent and selective 5-HT(1B/1D) agonists. , 1996, Journal of medicinal chemistry.
[90] G. Whitesides,et al. A trivalent system from vancomycin center dot D-Ala-D-Ala with higher affinity than avidin center dot biotin , 1998 .
[91] D. Acheson,et al. Multivalent inhibition of AB(5) toxins. , 2001, Journal of the American Chemical Society.
[92] R. Huber,et al. Bivalency as a principle for proteasome inhibition. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[93] L. Kiessling,et al. Tuning chemotactic responses with synthetic multivalent ligands. , 2000, Chemistry & biology.
[94] S. Yabuki,et al. [Denaturation and renaturation of deoxyribonucleic acids (author's transl)]. , 1973, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.
[95] David M. Gooden,et al. Additivity and the physical basis of multivalency effects: a thermodynamic investigation of the calcium EDTA interaction. , 2003, Journal of the American Chemical Society.
[96] R. Britten,et al. Repeated Sequences in DNA , 1968 .
[97] C Boesch,et al. 1H nuclear-magnetic-resonance studies of the molecular conformation of monomeric glucagon in aqueous solution. , 1978, European journal of biochemistry.
[98] T. Griffin,et al. An approach to predicting the stabilities of peptide nucleic acid:DNA duplexes. , 1998, Analytical biochemistry.
[99] J. Casasnovas,et al. Kinetics and Thermodynamics of Virus Binding to Receptor. , 1995, The Journal of Biological Chemistry.